Daiwa Securities Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-916
| Closed | -$13K | – | 1275 |
|
|
2025
Q4 | $13K | Sell |
916
-70
| -7% | -$688 | ﹤0.01% | 1171 |
|
|
2025
Q3 | $8K | Hold |
986
| – | – | ﹤0.01% | 1168 |
|
|
2025
Q2 | $6K | Hold |
986
| – | – | ﹤0.01% | 1146 |
|
|
2025
Q1 | $8K | Hold |
986
| – | – | ﹤0.01% | 1104 |
|
|
2024
Q4 | $9K | Sell |
986
-144
| -13% | -$1.5K | ﹤0.01% | 1126 |
|
|
2024
Q3 | $12K | Hold |
1,130
| – | – | ﹤0.01% | 1119 |
|
|
2024
Q2 | $11K | Hold |
1,130
| – | – | ﹤0.01% | 1159 |
|
|
2024
Q1 | $13K | Hold |
1,130
| – | – | ﹤0.01% | 1154 |
|
|
2023
Q4 | $16K | Hold |
1,130
| – | – | ﹤0.01% | 1142 |
|
|
2023
Q3 | $14K | Hold |
1,130
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q2 | $14K | Hold |
1,130
| – | – | ﹤0.01% | 1123 |
|
|
2023
Q1 | $13K | Hold |
1,130
| – | – | ﹤0.01% | 1095 |
|
|
2022
Q4 | $14K | Buy |
1,130
+86
| +8% | +$968 | ﹤0.01% | 1094 |
|
|
2022
Q3 | $11K | Hold |
1,044
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q2 | $11K | Buy |
1,044
+231
| +28% | +$1.9K | ﹤0.01% | 1137 |
|
|
2022
Q1 | $8K | Hold |
813
| – | – | ﹤0.01% | 1147 |
|
|
2021
Q4 | $9K | Sell |
813
-100
| -11% | -$1.11K | ﹤0.01% | 1155 |
|
|
2021
Q3 | $9K | Buy |
913
+423
| +86% | +$4.33K | ﹤0.01% | 1148 |
|
|
2021
Q2 | $5K | Hold |
490
| – | – | ﹤0.01% | 1072 |
|
|
2021
Q1 | $5K | Hold |
490
| – | – | ﹤0.01% | 1074 |
|
|
2020
Q4 | $11K | Sell |
490
-948
| -66% | -$19.4K | ﹤0.01% | 1012 |
|
|
2020
Q3 | $20K | Hold |
1,438
| – | – | ﹤0.01% | 992 |
|
|
2020
Q2 | $13K | Hold |
1,438
| – | – | ﹤0.01% | 1052 |
|
|
2020
Q1 | $13K | Hold |
1,438
| – | – | ﹤0.01% | 1040 |
|
|
2019
Q4 | $14K | Sell |
1,438
-184
| -11% | -$1.68K | ﹤0.01% | 1036 |
|
|
2019
Q3 | $13K | Buy |
1,622
+70
| +5% | +$760 | ﹤0.01% | 1018 |
|
|
2019
Q2 | $19K | Buy |
1,552
+129
| +9% | +$1.64K | ﹤0.01% | 1013 |
|
|
2019
Q1 | $19K | Buy |
1,423
+504
| +55% | +$6.16K | ﹤0.01% | 993 |
|
|
2018
Q4 | $9K | Hold |
919
| – | – | ﹤0.01% | 1003 |
|
|
2018
Q3 | $11K | Hold |
919
| – | – | ﹤0.01% | 1030 |
|
|
2018
Q2 | $14K | Hold |
919
| – | – | ﹤0.01% | 1029 |
|
|
2018
Q1 | $14K | Buy |
+919
| New | +$14K | ﹤0.01% | 1007 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Daiwa Securities Group's FOLD Position: Q1 2026 in Review
Daiwa Securities Group sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 916 shares — an estimated $13K sold.
Daiwa Securities Group first reported a position in FOLD in Q1 2018 and held it in 32 quarters. The position peaked at $20K in Q3 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Daiwa Securities Group reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 916 Amicus Therapeutics shares in Q1 2026, an estimated $13K.
- Daiwa Securities Group first reported a position in Amicus Therapeutics in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Amicus Therapeutics position peaked at $20K in Q3 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.